Globus Medical, Inc.
GMED
$71.04
$1.361.95%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 76.30% | 5,093.99% | -44.97% | -114.49% | -69.97% |
Total Depreciation and Amortization | -4.12% | 79.06% | 251.80% | 205.17% | 320.83% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 38.30% | 265.31% | 880.45% | 553.69% | 436.65% |
Change in Net Operating Assets | 160.06% | 2,288.07% | -141.16% | -102.38% | -204.64% |
Cash from Operations | 100.95% | 303.40% | 54.90% | -1.74% | 63.62% |
Capital Expenditure | 25.22% | -94.82% | -55.57% | -78.65% | -24.76% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | 99.97% | -- | -375.17% | 100.00% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -125.33% | -88.43% | -68.18% | -118.10% | 2,990.41% |
Cash from Investing | -132.48% | 81.49% | -119.87% | -523.80% | 630.08% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 6,561.83% | 612.49% | 345.08% | -29.76% | -93.29% |
Repurchase of Common Stock | 99.60% | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -304.32% | -64.46% | -62.93% | -1,488.07% | -12.34% |
Cash from Financing | 125.18% | 1,274.25% | 703.41% | -4,036.09% | -1,845.79% |
Foreign Exchange rate Adjustments | -1,132.85% | 92.08% | 771.36% | -12,638.46% | 58.64% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -13.85% | 891.38% | -36.51% | -268.45% | 1,055.40% |